Clebopride
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.424 |
Chemical and physical data | |
Formula | C20H24ClN3O2 |
Molar mass | 373.876 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Clebopride is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. Chemically, it is a substituted benzamide, closely related to metoclopramide.
A small Spanish study found that more adverse reactions are reported with clebopride than with metoclopramide, particularly extrapyramidal symptoms.[1]
Synthesis
Dopamine receptor antagonist related to metoclopramide, q.v.
The benzoic acid moiety common to many of the benzamides is prepared in a straightforward manner from the methyl ether of 4-aminosalicylic acid 1. Acetylation on nitrogen followed by chlorination gives intermediate 3; benzoic acid 4 is then obtained by removal of the acetyl group. Condensation of this acid with an aminopiperidine could be achieved by means of the mixed anhydride (prepared by reaction with ethyl chloroformate), which affords clebopride (5).
See also
References
- ^ Cuena Boy R, Maciá Martínez MA (1998). "[Extrapyramidal toxicity caused by metoclopramide and clebopride: study of voluntary notifications of adverse effects to the Spanish Drug Surveillance System]". Atencion Primaria (in Spanish). 21 (5): 289–95. PMID 9608114. Free full text
- ^ R. G. Spickett et al., DE 2513136; A. V. Noverola et al., U.S. patent 4,138,492 (1975, 1979 both to Anphar).
- ^ Template:Cite PMID